Used primarily in medical research, this compound is a derivative of thalidomide and is studied for its potential in modulating immune responses and inhibiting angiogenesis. It is of particular interest in the development of treatments for certain cancers, where it may help to reduce the growth of blood vessels that supply tumors. Additionally, it is explored for its role in managing inflammatory conditions and autoimmune diseases, leveraging its ability to influence cytokine production and immune cell activity. Researchers also investigate its application in combination therapies to enhance the efficacy of other anticancer drugs.